These findings suggest the possibility that at least one mechanism through which depressive symptoms, cognitive behavioral performance, and function improve with selective α2A agonism within the cognitive biotype + subgroup of depression is through modulation of the cognitive control circuit function. The gene discussed is IGKV2D-29; the disease is depressive symptom measurement.